Bleeding Disorders Treatment Market – Global Industry Insights and Forecast till 2025

Bleeding Disorders Treatment Market:

A bleeding disorder is a state in which the normal clotting function of blood is adversely affected. On an injury to the body, blood normally starts to clot to prevent major loss of blood. Occasionally, certain situations prevent blood from clotting properly, which can result in heavy or prolonged bleeding. Bleeding disorders can cause abnormal bleeding both outside and inside of the body. Some disorders can drastically increase the amount of blood lost by the body. Others cause bleeding to follow under the skin or in vigorous organs, such as the brain. Normal blood clotting involves blood components called ‘platelets’ and as many as there are 20 different plasma proteins in body called as blood clotting or coagulation factors. These factors interact with other chemicals to form a substance called fibrin which stops bleeding. Complications can occur when certain factors are low or missing in body. Bleeding problems can range from mild to severe. Some bleeding disorders are present at time of birth and some are passed through families (inherited).

According to American Society of Hematology, in 2016, around 20,000 people in the U.S. suffer from hemophilia, a condition that is predominantly observed in males. Hemophilia is the most well-known inherited bleeding disorder, although it is rather rare. On the other hand, many people are affected by von Willebrand disease, the most common inherited bleeding disorder in the U.S. caused by clotting proteins. This disease can affect both males and females and is found in nearly 1% of the U.S. population. And according to the Centers for Disease Control and Prevention (CDC) statistics, in the U.S. around 400 newborns suffer from hemophilia every year.

Get an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/527

Bleeding Disorders Treatment Market

On the basis of type of disorder, the global bleeding disorders treatment market is classified into:

  • Hemophilia A

  • Hemophilia B

  • von Willebrand Disease (vWD)

On the basis of drug class, the global bleeding disorders treatment market is classified into:

  • Plasma Derived Coagulation Factor Concentrates

  • Recombinant Coagulation Factor Concentrate

  • Desmopressin

  • Antifibrinolytics

  • Fibrin sealants

  • Others

Generic products to be the growth factor for bleeding disorders treatment market

The bleeding disorder treatment market is driven by the large customer base, growing awareness about the bleeding disorders and available cures, and favorable compensation policies. Patent expiry of existing brands will also provide generic drug manufacturers opportunities to enter the lucrative bleeding disorder therapeutics market. Market for bleeding disorder treatment is mostly focused towards western countries of North America and Europe, owing to the high price of branded drugs. Low cost drugs will help in market penetration in under developed and developing countries, where patients cannot afford high cost of medical treatment.  Hence, availability of cheap generic drugs will boost market growth in the countries of Middle East and Africa, Asia-Pacific (APAC), and Latin America.

North America is estimated to contribute the largest share of the market throughout the forecast period. The market in APAC is estimated to register the highest growth during the forecast period, owing to increasing awareness of these disorders in the emerging economies such as India and China.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/527

The global bleeding disorder treatment market is highly competitive in nature. Technological advances will expand the boundaries of the market by adding new products such as Shire launched Vonvendi in the U.S. (In 2016), bringing the first recombinant von Willebrand factor treatment to market eight months after winning approval from the Food and Drug Administration(FDA). Key players operating in the global bleeding disorders treatment market are Bayer Healthcare, Biogen Idec, Novo Nordisk, Xenetic Biosciences, Shire, Sanofi, Cangene Corporation, CSL Behring, Alnylam Pharmaceuticals, Pfizer, Inc., Novo Nordisk, Amgen, Inc., Janssen Pharmaceuticals, and Octapharma.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Telemedicine Market : Global Industry Analysis and Forecast 2017 – 2025

Telemedicine Market Overview:

Telemedicine involves the use of information technology and telecommunication for the delivery of healthcare services such as health assessments or consultations over the telecommunications infrastructure. It helps the healthcare professional to diagnose, evaluate and treat patients without the need for an in-person visit and are also very useful to save lives at time of critical care and emergency situations. Telemedicine is of great help for distant rural areas as they help in overcoming the distance barriers to avail medical services at the time of requirement. Telemedicine enables the doctors to be connected through a variety of electronic means, including video conferencing, email and electronic messaging platforms. This reduces the overall cost of medical care for patients and increase healthcare accessibility.

Seeing the potential that the telemedicine provides, the World Health Organization (WHO) established global observatory for eHealth (GOe) to analyze the benefits that information and communication technologies can bring to healthcare supporting patient’s wellbeing. In 2009, the global observatory was assigned to determine the status of telemedicine at the national, regional and global level. The survey examined the four fields of telemedicine which includes telepathology, teledermatogy, telepsychology and teleradiology along with four mechanisms that will help in the development of telemedicine across all nations.

The conventional form of telemedicine that involved the use of telephone and radio have improved by the involvement of videotelephony, advanced diagnostic methods supported by various applications and tele medical devices to support in-home care.

Get an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/548

Telemedicine market taxonomy:

On the basis of services provided, the telemedicine market is classified into:

  • Tele-monitoring
  • Tele-education
  • Tele-consultation
  • Tele-training
  • Tele-care
  • Tele-surgery

On the basis of application, the telemedicine market is classified into:

  • Neurology
  • Orthopedics
  • Emergency care
  • Cardiology
  • Dermatology
  • Internal medicine
  • Others

On the basis of end user, the telemedicine market is classified into:

  • Hospitals
  • Clinics
  • Others

Burgeoning growth of the internet infrastructure and smartphone proliferation creates a conducive environment for growth of the global telemedicine market. Also, the rise in demand for personalized healthcare augments market growth. In 2013, American Telemedicine Association (ATA) stated the cost effectiveness of telemedicine through various research outcomes. For instance, a research was conducted in 2011 with implementation of Health Buddy Program which integrated a telehealth tool for chronically ill Medicare beneficiaries. It was found that patients who used this telemedicine had significant savings than patients who did not use it. A similar study was done in 2012 in New Mexico, which proved that costs in ‘Hospital at Home’ were 19% lower compared to care in hospitals for similar inpatients

More than 15 million Americans received medical care through telemedicine in 2016, according to American Telemedicine Association (ATA). This number is expected to grow further by 30% in 2017. Alongside ATA also issued several acts such as CHRONIC Care Act and CONNECT for Health Act in 2017 to support the growth of telemedicine across all nations. The Assembly Health Committee of New Jersey recently in 2017 legally defined the practice of telemedicine, user eligible for it and technology that can be used. This is expected to boost the telemedicine market in the region significantly during the forecast period. Another development in North Carolina allows professionals to video monitor and collect data on every far flung ICU patient through TeleICU. Furthermore, telemedicine developments are also observed in Latin America. The Government of Paraiba, Brazil introduced a telemedicine project for remote screening of hearth defects in children in 2015.

Alongside there are various medical policies available that support the telemedicine services. For instance, the Congressional Budget Office (CBO) expanded its Medicare coverage for services like consultation, individual psychotherapy and pharmacologic management on 18th May 2017.

Lack of resources, infrastructure and high technological cost may hamper the market growth in emerging economies such as India, Brazil, and African countries.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/548

Strategies implemented by market players to tap the emerging markets:

Key players in telemedicine market are Siemens Healthcare, McKesson, Cardio Net Inc., Cerner, IBM Corporation, Medtronic, Inc, Philips Healthcare Honeywell Life Care Solutions, GE Healthcare, AMD Telemedicine and Cisco Systems. Market players are implementing various strategies to gain share in the telemedicine market. For instance, Doc+, a Russian digital health company combined telemedicine with digital-enabled house calls through which doctors can offer consultations, sick notes, prescriptions, and a number of diagnostic tests over electronic platform in 2016.

Furthermore, in 2017, ZH healthcare collaborated with Curavi Health Telemedicine Company to deliver workflow and electronic health records (EHR) solutions that will help deliver telemedicine solutions and physician care to the nursing-home bedside.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Hyperbaric Oxygen Therapy (HBOT) Devices Market: Global Industry Analysis and Forecast 2017 – 2025

Hyperbaric Oxygen Therapy Devices Market Overview:

Hyperbaric oxygen therapy (HBOT) devices are used to deliver 100% pure oxygen to tissues in the body under high atmospheric pressure. During HBOT, the pressure is increased to three times the normal atmospheric pressure, creating high amount of partial pressure of oxygen. Under normal conditions, one atmosphere absolute are subjected to be around 14.7 pounds per square inch of pressure and the air we normally breathe is composed of 21% oxygen and 79% nitrogen. Breathing in 100% oxygen, the body is exposed to rise in atmospheric pressure, the oxygen molecules become condensed and this allows to breathe a higher amount of partial pressure of oxygen, where in turn oxygen dissolves in the plasma around 10 to 15 times greater than normal. This super-saturation of oxygen in the body’s tissues promotes the increase in capillary growth, increase in white blood cell (WBC) activity, new tissues development, increase oxygen tension in hypoxic areas, reduction in the size of gas bubbles and numerous other physiological effects.

HBOT devices play a vital role in the field of medicine, these devices help in the treatment of many diseases such as asthma, HIV/AIDS, bell’s palsy, Parkinson’s disease, spinal cord injuries, hepatitis, migraines, multiple sclerosis, stroke and sport injuries. Moreover, HBOT devices have Food and Drug Administration (FDA) approval for treating decompression sickness, thermal, necrotizing soft tissues infection and burn injury. HBOT devices are also used in the off-label (means the medication is not specified in the FDA’s approved packaging label) medical induction treatment such as brain injuries and cancer. Such high preference from the patients and physicians for HBOT in medical field has powered growth in the HBOT devices market. The market is expected to rise in the forecast period, especially across the North America, Europe and Asia-Pacific region.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/553

Hyperbaric oxygen therapy (HBOT) devices market by taxonomy

Hyperbaric Oxygen Therapy Devices Market, by Product Type:

  • Monoplace HBOT Devices

  • Topical HBOT Devices

  • Multiplace HBOT Devices

by Application:

  • Wound Healing

  • Decompression Sickness

  • Infection Treatment

  • Gas Embolism

  • Others

by Geography:

  • North America

  • Latin America

  • Europe

  • Asia Pacific

  • Middle East

  • Africa

Increase in number of wound healing treatment and cosmetic procedures is expected to support the growth of hyperbaric oxygen devices market

The growth in usage of hyperbaric oxygen therapy in healing of wound and cosmetic procedure is one of the factor to rise in demand in forecast period and also the rise in healthcare costs, increase in prevalence of diseases such as asthma, diabetes, and growth rate in aging population are some of the factors that can be accounted for the largest market share. Asia Pacific market is expected to grow in the forecast period due to the increase in income, growth in medical tourism industry, and rise in public awareness benefits HBOT devices.

People who are suffering from diabetes are at increased risk for a wound development. According to the Center for Disease Control and Prevention (CDC) in the U.S., it was diagnosed that around 21.0 million people suffered from diabetes in 2014. The U.S. is expected to be the growth engine of the global HBOT market through the forecast period. This is mainly attributed to increase in incidence rate of diabetes, and rising chronic disease and acute wounds and simultaneously growth in treatment rate due to the developed healthcare technology, healthcare expenditure by the government and high disposable income are some of the factors that are expected to support the market in future near.

As per The American Society of Plastic Surgeons (ASPS) around 15.9 million minimally invasive cosmetic procedures were performed in 2014-2015 in the U.S. Moreover, increasing number of metrosexual men is in turn expected to create a highly conducive environment for growth of the HBOT market.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/553

Key players in the market:

  • Fink Engineering

  • HAUX-LIFE-SUPPORT

  • Gulf Coast Hyperbarics, Inc.

  • IHC Hytech B.V. (Royal IHC)

  • HEARMEC; Hyperbaric

  • Sechrist Industries, Inc.

  • OxyHeal International

  • Haux-Life-Support GmbH

  • HYPERBARIC S.A.C.

  • Hyperbaric Technology (HyTech) B.V.

  • Sands Hyperbaric Corporation

  • SOS Medical Group Ltd.

  • Hearmec Co., Ltd. and Fink Engineering Pty. Ltd.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Extracorporeal Shock Wave Lithotripsy Market – Global Industry Insights till 2025

Extracorporeal Shock Wave Lithotripsy Market Overview:

Extracorporeal shock wave lithotripsy is a non-invasive treatment for kidney stone and biliary calculi, using an acoustic pulse and are also used for salivary stones and pancreatic stones. The lithotripter supplies a high intensity acoustic pulse to crush the stone causing minimal collateral damage to the normal tissue and the shock waves break the stones into smaller portion. Extracorporeal shock wave lithotripsy are widely used by the physician globally due to its important characteristic such as non-invasiveness, recovery time, reduced pain and reduced hospital stay. Extracorporeal shock wave lithotripsy success rate is high for patients with smaller stones such as less than 1 centimeter. Also, rise in prevalence of obesity and increasing diabetic patient population also favors growth of the extracorporeal shock wave lithotripsy market.

Furthermore, rising incidence of kidney stones and ureter stones are expected to boost growth of the market in the near future. Rampant development of healthcare infrastructure in emerging economies and growing awareness about the availability of technically developed equipment to carry out the procedures favors growth of the market. After extracorporeal shock wave lithotripsy treatment, patient can resume daily activities within one to two days. According to the National Health and Nutrition Examination Survey held in 2012, prevalence of kidney stone was found to be higher in women than in males.

Get an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/513

Extracorporeal Shock Wave Lithotripsy Market Taxonomy

By Technology

  • Electrohydraulic Technique

  • Electromagnetic Technique

  • Piezoelectric Technique

By Application

  • Kidney Stones

  • Uretic Stones

  • Pancreatic Stones

  • Salivary Stones

By End User

  • Hospital

  • Clinics

Extracorporeal shock wave lithotripsy market is being fuelled by rise in incidence of kidney stones

Extracorporeal shock wave lithotripsy is a valuable tool for eradication of stones from kidney, ureter, gallbladder, salivary gland, or salivary duct. Extracorporeal shock wave lithotripsy is used to find the stone and break it down into smaller fragments. Extracorporeal shock wave lithotripsy generates shockwaves, which are then focused onto the stone present in body with negligible diversion of energy that favors minimal damage to tissue. Extracorporeal shock wave lithotripsy is also most effective in treatment of non-obstructing renal calculi. Whereas the composition and density of stone decides the rate of shockwaves to be generated. According to Centers for Disease Control and Prevention, number of adults diagnosed by kidney disease are 4.9 million in the U.S. in 2015.

Furthermore, improvement in healthcare facilities, awareness regarding available technique promote the market of extracorporeal shock wave lithotripsy.

Growth engines for extracorporeal shock wave lithotripsy market

Most populated and urbanized regions such as North America, Asia-pacific and European region in the world that uses the advanced devices for treatment purpose shows the largest extracorporeal shock wave lithotripsy market. Europe also favors the growth of market due to increased government investment. The high growth in India and China can be attributed to government and venture capital investments in the field of extracorporeal shock wave lithotripsy to develop the market. Increase in incidence of kidney stone disease in the U.S. also favors the market of extracorporeal shock wave lithotripsy.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/513

The key players dominating the global extracorporeal shock wave lithotripsy market

Investment in medical device technology and R&D have increased the competition among the manufacturers. Whereas manufacturers are focusing on offering advanced features to extracorporeal shock wave lithotripsy at affordable prices to gain a competitive edge in the market. The key players operating in the market are Boston Scientific Corporation, C.R. Bard Inc., Lumenis LTD, GE Healthcare and Siemens AG.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Optical Imaging Market : Industry analysis 2017–2025

Optical Imaging Market Overview:

Optical imaging is an emerging non-invasive technique used for capturing images of the internal parts of the body. Visible light and photons are incorporated to take the complete image of internal organs and tissues, the images of smaller structures are also taken, which include cells and molecules. Optical imaging uses the properties of photons such absorption and scattering, the spectra of light measures and perceives the properties of organs and soft tissues. Although, optical imaging technology is at its early phase of development, a wide range of technological advantages are offered over current imaging technologies. The images are referred by doctors for diagnosis and treatment of various diseases and by scientists for carrying out diverse research work. Optical imaging has proved to be much harmless and efficient compared to MRI and X-ray that use ionizing radiation for imaging.

Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/439

The non-invasive technology and increasing prevalence is expected to boost the growth of optical imaging market

According to the World Health Organization in 2012, population above 65 years has grown the highest and is expected to rise from 13% in 2010 to 53% by 2020. The key factors contributing to the growth of the optical imaging market are high prevalence of neurological and ophthalmologic disorders, increase in R&D activities in the life sciences sector, preclinical research, rising demand for radiation free imaging modalities in drug discovery processes. Moreover, the provision to acquire in-depth images of complex components of eyes, surface tissues, membranes vascular systems and gastrointestinal tract are driving the growth of the global market. Furthermore, vast application scope of the advance optical imaging products, operator and patient safety and comfort are other factors driving the growth. The emerging state of optical imaging market is also due to the use of non-ionizing radiations that reduce the harmful radiation exposure of patients.

Scanning laser microscopes used to identify cancer without painful biopsies and is expected to drive the global optical imaging market

The global optical imaging market is segmented on the basis of product type, therapeutic area, application, end user and geography.

On the basis of product type,

  • Imaging systems

  • Optical Imaging Systems

  • Spectral Imaging Systems

  • Software

  • Lenses

  • Illumination systems

  • Cameras

  • Others

On the basis of therapeutic area,

  • Neurology

  • Oncology

  • Dentistry

  • Dermatology

  • Ophthalmology

  • Cardiology

  • Others

On the basis of applications,

  • Pre-clinical and clinical research

  • Intra-operative Imaging

  • Pathological imaging

On the basis of end user,

  • Diagnostic Imaging Centers

  • Hospitals

  • Research Laboratories

Development in healthcare infrastructure and rising prevalence of chronic diseases is expected to dominate North American optical imaging market

Regional segmentation of the optical imaging market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East and Africa. According to the National Institute of Aging in 2015, 524 million people were aged 65 or older in 2010 and by 2050 it is estimated to nearly triple to about 1.5 billion, which will represent 16 percent of the world’s population. North America dominates the global optical imaging industry as the high usage of the optical imaging technologies in applications like oncology, dentistry and dermatology. It also comprises of huge geriatric population suffering from disorders that require optical imaging devices, which in turn will contribute towards the growth of optical imaging market. Key factors responsible for the rapid growth of Asia-Pacific market is the presence of high patient population suffering from various disorders along with high prevalence of chronic diseases. Increasing healthcare awareness, development of healthcare infrastructure, growing purchase power will fuel the growth of global optical imaging market.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/439

Product launch, collaborations and acquisition by Abbott is expected to create high growth in optical imaging market

Key players operating in the optical imaging market are Abbott, Bioptigen Inc., Topcon Medical systems, Inc., Carl Zeiss Meditec AG with the strategies that include collaboration & merger, product launch. The acquisition of St Jude Medical in April 2016 by healthcare giant Abbott has created tremendous growth in neuromodulation, cardiovascular and atrial fibrillation market. Other market players include Heidelberg Engineering, Inc., Santec Corporation, Headwall Photonics, Inc., AGFA Healthcare, Headwall Photonics, Inc. and Optovue, Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Colostomy Bags Market :Industry analysis 2017–2025

Colostomy Bags Market Overview:

Colostomy is a surgical procedure in which an opening is formed by drawing the healthy end of the large intestine or colon by an incision in the anterior abdominal wall and then suturing and setting it into place. This helps the patient in better bowel motions through the stoma and collected in special disposable colostomy bag, which fits over the stoma and sticks to the skin. Colostomy can be permanent or temporary, as colostomy can be reversed by joining two ends together. Colostomy bags market is gaining traction due to increasing prevalence of diseases such as irritable bowel syndrome, multiple sclerosis, Crohn’s disease and cancer. Besides these colostomy can be performed due to birth defects or accidental injury. The broad spectrum regarding the causes for the disease is expected to favor the growth in colostomy bags market in the near future.

Colostomy bags market is backed by some of the factors as they does not bring significant changes in lifestyle as most of the people are allowed to follow the diet as earlier and perform their daily routine after the surgery. Furthermore, to avoid infections around colostomy bag due to spillage of stool, sweating, dislocation of colostomy bags wide range of accessories are provided, which includes support belts, girdles, deodorizers, skin protective wipes and stoma paste. Moreover, there are different types of colostomy bags such as closed bags, drainable bags, one piece system and two-piece system that are designed according to patients need.

Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/503

Colostomy bags market taxonomy

By Product Type

  • Closed Pouch

  • Drainable Pouch

  • Two-Piece System

  • One-Piece System

By End Users

  • Hospital

  • Ambulatory Surgical Centers

  • Homecare Settings

Rise in incidence of Crohn’s disease and bowel cancer is expected to fuel the growth of colostomy bags market in the near future

Crohn’s disease is a type of inflammatory bowel disease (IBD) which can affect any part of gastrointestinal tract from mouth to anus which increase the market of colostomy bags. According to Centers for Disease Control and Prevention (CDC), 1.0-1.3 million people suffer from inflammatory bowel disease (IBD) as Crohn’s disease is more common in smokers. Whereas each year in the U.S. around 54,000 men and 17,000 women get bladder cancer according to Centers for Disease Control and Prevention (CDC), which significantly supports the rise in growth percentage of colostomy bags industry. The statistics provided above are expected to be a set of crucial factors that supports the growth in colostomy bags market over the forecast period.

Regional growth engines of the colostomy bags market

On the basis of regional segmentation, the global colostomy bags market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The global market is projected to show growth expansion in Asia Pacific due to the rise in incidence of colorectal cancer, increase in aging population and increase in medical tourism. According to Centers for Disease Control and Prevention (CDC) report in 2014, the highest incidence of colorectal cancer was reported in Asia Pacific and Hispanic with approximately 35 people out of 100,000 in 2013.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/503

The key players dominating the global colostomy bags market

Providers in the market offer a broad range of colostomy bags and accessories and in increase in adoption of market strategies such as online marketing due to advanced technology to manufactures innovation in product competition in market is increasing. The key players operating the market of colostomy bag includes, Coloplast, ConvaTec, TG Eakin Hollister, Marlen, B. Braun Oakmed, and Welland Medical.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

The global Interventional neurology market is expected to expand at a CAGR of 5.3% till 2024

The Global Interventional Neurology Market is projected to reach USD 2,684.6 million by 2024, according to a new report by published by Coherent Market Insights. Recommendations from the American Heart Association and American Stroke Association to use neurointerventional devices in stroke is a major factor boosting market growth.

Increasing demand for minimally invasive procedures is one of the prime factors driving adoption of neurointerventional devices worldwide. The American Heart Association and American Stroke Association recommends use of neurointerventional devices in treating stroke, due to which there has been an augmented demand for these devices in the recent past. In order to capitalize on this highly lucrative growth opportunity, a range of new products such as Solitaire stent retriever, EmboTrap stent retriever, and Penumbra 3D Revascularization Device have been launched in the recent past.

Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/56

Developed economies such as the U.S., Canada, U.K., Australia, Japan, and Germany are witnessing rapid shift from conventional surgical methods to minimally invasive therapies. Moreover, there is a shift towards adopting detachable and bare platinum coils as against the highly priced coated coils. According to the Brain Aneurysm Foundation, around six million people in the U.S. i.e. one in 50 people suffer from brain aneurysm every year. High incidence rate of stroke and aneurysm is expected to continue strengthening demand for neurointerventional devices in the U.S. market.

The global Interventional neurology market is witnessing strategic agreements among leading players focusing on diversifying their product portfolio and increasing their market presence.

  • In 2016, Codman & Shurtleff, Inc. inked an exclusive distribution agreement with InNeuroCo, Inc. for its intermediate catheter and super distal access device in the U.S. and European markets
  • In 2015, Medtronic PLC acquired Lazarus Effect, a California-based medical device company engaged in development of acute ischemic stroke products for around US$ 100 million. Lazarus Effect was acquired with an aim to enhance Medtronic’s neurovascular business and related portfolio.

Advent of innovative solutions that enhance the outcomes of surgeries are fueling demand for neurointerventional devices

  • Medical University of South Carolina (MUSC) is investigating the safety and success rate of ADAPT – direct-aspiration first pass technique that removes the clot in a single-pass
  • FDA expanded the approval of Solitaire stent retriever device of Medtronic PLC for reduction of stroke-related disability. This device can now be used in patients with large vessel occlusion, proximal anterior circulation, and smaller core infarcts to reduce paralysis, and other stroke-related disabilities.
  • CE approved EmboTrap stent retriever platform, the EmboTrap II Revascularization Device from Neuravi Ltd. This new device enables removal of clots of different lengths with ease.

Get discount on sample copy : https://www.coherentmarketinsights.com/insight/request-discount/56

Key takeaways of the market include:

  • There are a range of neurointerventional devices such as embolic coils, carotid stents, intracranial stents, neurovascular thrombectomy devices, embolic protection devices, and flow diverter devices available in the market. Embolic coils was the largest segment and accounted for 32.5% share (in terms of revenue) in 2015. This is mainly due to these being the mainstay of endovascular treatment for brain aneurysms and hemorrhage.
  • Demand for stent retrievers is anticipated to grow at a rapid pace during the forecast period (2016 – 2024). This is mainly attributed to these being used as a one-step technique for device deployment and clot retrieval. The launch of this device in Japan is anticipated to also contribute towards the market growth in Asia Pacific.
  • Introduction of new techniques such as flow disruption and ADAPT aspiration technique is expected reduce the revenue share of coiling technique segment, and is projected to account 34.3% of the total market revenue by 2024
  • Demand for neurointerventional devices is analyzed to be high in hospitals as compared to ambulatory centers, due to growing number of surgical procedures in hospitals. The hospitals end use segment is analyzed to expand at a CAGR of 5.2% during the forecast period.
  • In 2015, North America dominated the global Interventional neurology market, with the contribution of the region estimated at US$ 701.9 million. Increasing incidence rate of brain aneurysm and ischemic strokes along with favorable government policies such as Medicare and Medicaid is expected to bolster sales of interventional neurology devices over the forecast period.
  • Growing focus on introducing technological advanced devices is expected to drive market growth in the long run
  • Stryker Corporation’s subsidiary Concentric Medical’s Trevo XP ProVue Retriever received FDA approval for its use in strokes in November 2016
  • Penumbra 3D Revascularization Device Trial successfully met the primary trial endpoints in 2016

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com